Benralizumab in severe eosinophilic asthma: a comprehensive systematic review and meta-analysis of randomized controlled trials evaluating lung function, asthma control, and safety outcomes
Systematic Reviews · 03.06.2026 · 15 (1)
DOI: 10.1186/s13643-026-03215-9 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Systematic Reviews, online erschienen am 03.06.2026. Verfasst von Abbas Al Mutair und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical surgical department, College of Nursing, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Anti-Asthmatic Agents, Antibodies, Monoclonal, Humanized, Asthma, Pulmonary Eosinophilia. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Princess Nourah bint Abdulrahman University, Researchers Supporting Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical surgical department, College of Nursing, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
- Research Center, Almoosa Health Group, Al-Ahsa, Saudi Arabia.
- Almoosa College of Health Science, Al-Ahsa, Saudi Arabia.
- School of Nursing, Queens University Belfast, Belfast, Ireland.
- Department of Maternity and Pediatric Nursing, College of Nursing, Princess Nourah bint Abdulrahman University, 11671, Riyadh, Saudi Arabia.
- Department of Medical and Surgical Nursing, College of Nursing, Princess Norah bint Abdurrahman University, Riyadh, Saudi Arabia.
ORCID-Profile: Muhammad Daniyal
Förderung
- Princess Nourah bint Abdulrahman University, Researchers Supporting Project
Zitieren
APA
Al Mutair, A., Alabbasi, Y., Alharbi, H. F., Alyami, H., Al-Shammari, H. M., Al-Omari, A. A., Bomozah, E. A., Aljarameez, F., & Daniyal, M. (2026). Benralizumab in severe eosinophilic asthma: a comprehensive systematic review and meta-analysis of randomized controlled trials evaluating lung function, asthma control, and safety outcomes. Systematic Reviews, 15(1). https://doi.org/10.1186/s13643-026-03215-9
Vancouver
Al Mutair A, Alabbasi Y, Alharbi HF, Alyami H, Al-Shammari HM, Al-Omari AA, et al. Benralizumab in severe eosinophilic asthma: a comprehensive systematic review and meta-analysis of randomized controlled trials evaluating lung function, asthma control, and safety outcomes. Systematic Reviews. 2026;15(1). doi:10.1186/s13643-026-03215-9
BibTeX
@article{AlMutair2026,
author = {Al Mutair, Abbas and Alabbasi, Yasmine and Alharbi, Hanan F and Alyami, Hanan and Al-Shammari, Haifa Mohmmed and Al-Omari, Abdullah Awad and Bomozah, Eman A and Aljarameez, Faiza and Daniyal, Muhammad},
title = {Benralizumab in severe eosinophilic asthma: a comprehensive systematic review and meta-analysis of randomized controlled trials evaluating lung function, asthma control, and safety outcomes},
journal = {Systematic Reviews},
year = {2026},
volume = {15},
number = {1},
doi = {10.1186/s13643-026-03215-9}
}
EUVIMED